Moleculin Biotech, Inc.
NASDAQ:MBRX
0.9502 (USD) • At close April 21, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -21.763 | -29.769 | -29.025 | -15.894 | -17.355 | -13.205 | -11.876 | -9.805 | -3.926 | -0.748 |
| Depreciation & Amortization
| 0.126 | 0.127 | 0.13 | 0.164 | 0.2 | 0.199 | 0.068 | 0.018 | 0.006 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | -6.728 | -2.34 | -4.063 | 0 | -1.387 | 0 | 0 |
| Stock Based Compensation
| 1.726 | 1.984 | 2.275 | 2.373 | 1.68 | 1.537 | 1.14 | 0.707 | 0.411 | 0 |
| Change In Working Capital
| 0.231 | 1.622 | 0.224 | 1.038 | -0.041 | -2.142 | 1.61 | 0.542 | -0.256 | 0.323 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.468 | 0.403 | 0.731 | 0.235 | -1.024 | 0.907 | 0.436 | 0.411 | -41.128 | 0 |
| Other Working Capital
| 0.699 | 1.219 | -0.507 | 0.803 | 0.983 | -3.049 | 1.174 | 0.131 | 40.872 | 0.323 |
| Other Non Cash Items
| -4.182 | 1.935 | -1.243 | 0.096 | 0.085 | 0.476 | -3.145 | 2.601 | 0.424 | 0.002 |
| Operating Cash Flow
| -23.862 | -24.101 | -27.639 | -18.951 | -17.771 | -17.198 | -12.203 | -7.324 | -3.765 | -0.424 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.013 | -0.124 | -0.067 | -0.019 | -0.376 | -0.052 | -0.417 | -0.028 | -0.021 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0.002 | 0.001 | 0 | 0 | -0.1 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.013 | -0.124 | -0.067 | -0.019 | -0.374 | -0.051 | -0.417 | -0.028 | -0.121 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.305 | 0.45 |
| Common Stock Issued
| 4.66 | 4.166 | 0 | 74.684 | 22.561 | 19.292 | 12.025 | 6.071 | 9.17 | 0.002 |
| Common Stock Repurchased
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.025 | 0.485 | -0.023 | 0.04 | -0.012 | 1.562 | 0.02 | 3.988 | -0 | 0 |
| Financing Cash Flow
| 4.635 | 4.651 | -0.023 | 74.724 | 22.549 | 0.021 | 12.045 | 10.059 | 8.865 | 0.452 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -0.032 | -0.021 | -0.029 | -0.024 | 0.034 | -0.004 | -0.005 | 0 | 0 | 0 |
| Net Change In Cash
| -19.272 | -19.595 | -27.758 | 55.73 | 4.438 | 3.601 | -0.58 | 2.707 | 4.979 | 0.028 |
| Cash At End Of Period
| 4.278 | 23.55 | 43.145 | 70.903 | 15.173 | 10.735 | 7.134 | 7.714 | 5.007 | 0.028 |